ArticleSurgical endoscopy2026
Patient's weight-based indocyanine green dose for fluorescence angiography with led imaging system in left-sided colorectal resections.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOne limitation of indocyanine green (ICG) fluorescence angiography (FA) is that, following intravenous administration, the dye produces residual background fluorescence impeding accurate perfusion assessment if a second injection is required. This study aimed to identify the optimal patient weight-based ICG dose able to create a strong fluorescent signal at the level of descending colon transection and, at the same time, to ensure none or minimal background fluorescence before second FA for perfusion assessment of colorectal anastomosis.
methodsThe first part of the study was used to define the ideal ICG doses, for overlay mode and monochromatic mode, to perform FA through the bisection method. In the second part of the study, the two doses were tested in 40 consecutive left-sided colorectal resections each, using an LED fluorescence system. Fluorescence intensity was assessed subjectively by a dose-blinded surgeon and objectively using image analysis software at three time points: after first ICG injection to identify descending colon transection line; before second injection, to define background fluorescence; after second injection, to define colorectal anastomosis fluorescence intensity.
resultsSixteen patients were included in the first part of the study and 80 patients in the second one. The ICG doses equal to 0.027 mg/kg, for overlay mode, and 0.0108 mg/kg, for monochromatic mode, are associated with medium-to-maximum subjective and objective signal intensity during perfusion assessment of both descending colon, during transection line identification, and colorectal anastomosis. Background fluorescence was assessed a median of 19 (9-90 overlay, 10-96 monochromatic subgroups) minutes after dye injection, showing no recognizable fluorescence in overlay subgroup and minimal fluorescence in monochromatic subgroup.
conclusionICG doses calculated at 0.027 mg/kg, for overlay mode, and 0.0108 mg/kg, for monochromatic mode allow ideal intraoperative visualization during perfusion assessment of left-sided colorectal resections with ICG FA using an LED system.
Indexed as
Identifiers
42661066What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.